2015
DOI: 10.1002/rcm.7289
|View full text |Cite
|
Sign up to set email alerts
|

Stable Isotope Labeling by Amino acidin Vivo(SILAV): a new method to explore protein metabolism

Abstract: The Stable Isotope Labeling Amino acid in Vivo (SILAV) method presented here, which yields unprecedented information about protein metabolism in humans, constitutes a promising new approach which certainly holds great potential in the field of clinical proteomics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 29 publications
(52 reference statements)
0
10
0
Order By: Relevance
“…Lastly, the stable isotope labeling approach recently described by Lehmann et al ( 2015 ) could be of great value for quantifying: (i) the rates of synthesis and clearance of a large range of proteins in the lumbar and ventricular CSF; and (ii) the large interindividual differences in protein concentration found in patients with CH.…”
Section: Discussionmentioning
confidence: 99%
“…Lastly, the stable isotope labeling approach recently described by Lehmann et al ( 2015 ) could be of great value for quantifying: (i) the rates of synthesis and clearance of a large range of proteins in the lumbar and ventricular CSF; and (ii) the large interindividual differences in protein concentration found in patients with CH.…”
Section: Discussionmentioning
confidence: 99%
“…After the validation of proteomics results using enzyme‐linked immunosorbent assays, the authors of this work related the levels of fibrinogen, plasminogen, transthyretin, transferrin, and Tamm‐Horsfall proteins levels with the congenital bilateral hydronephrosis . Due to the small volume and difficulty to obtain, cerebrospinal fluid (CSF) has only been used in a few temporal studies to investigate the effect of the gamma‐secretase inhibitor semagacestat in the CSF peptidome, or to develop a stable isotope labeling by amino acids in vivo methodology . Further biofluid samples such as sperm, dental pellicle, Gingival crevicular fluid, broncho alveolar lavage, and breast milk have also been studied to a lesser extent (, Supporting Information).…”
Section: Protein Expressionmentioning
confidence: 99%
“…D3‐Leu has been frequently used to endogenously label proteins even though alternatives, such as carbon‐13 and nitrogen‐15, that provide better separation between the isotopologs of unlabeled and labeled peptides, are available . However, isotopolog separation does not guarantee reduced interference, even in MS2 scans that contain less interference than in MS1 scans .…”
Section: Introductionmentioning
confidence: 99%
“…Endogenous labeling typically uses a constant tracer infusion strategy with an initial bolus, achieving maximum enrichment at the equilibrium plateau. Even with the primed constant infusion method however, tracer incorporation is very low for most plasma proteins . Our PRM strategy, which is built on concepts derived from data‐independent acquisition (DIA) methods and neutron encoded mass signatures (NeuCode) , circumvents the technical issues above by co‐isolating and fragmenting the D0‐ and D3‐Leu peptides for PRM at the highest resolution to separate the 2HM3 ion from background ions and its M3 isotopolog .…”
Section: Introductionmentioning
confidence: 99%